The underlying mechanism of the GVT effect primarily involves the recognition of tumor-specific antigens by the donor's immune cells. This recognition leads to the activation of donor T-cells and natural killer (NK) cells, which subsequently target and destroy the malignant cells. The process is complex and influenced by several factors, including the type of cancer, the compatibility between donor and recipient, and the presence of specific immunological markers.
